Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product to treat amblyopia, the leading cause of vision loss among children. For more information, visit luminopia.com. Please see Luminopia Directions For Use for more information: luminopia.com/dfu
| Website | http://www.luminopia.com |
| Employees | 24 (16 on RocketReach) |
| Founded | 2016 |
| Address | 625 Massachusetts Ave, Cambridge, Massachusetts 02139, US |
| Technologies |
JavaScript
,
HTML
,
Twitter
+17 more
(view full list)
|
| Industry | Biotechnology |
| Keywords | Digital Health Solutions, Digital Therapeutics, Patient Engagement Platform, Therapeutic Applications, Fda Approved Treatments, Clinical Trials Technology, Brain Health Technology, Medical Technology Software, Vision Impairment Solutions, Optometry Technology, Healthcare Technology Solutions, Visual Rehabilitation, Healthtech Innovation, Eye Care Technology, Vision Therapy |
| Competitors | Osso VR, binah.ai, Second Sight Medical Products, Vivid Vision, CureMetrix, Smart Vision Labs, Eyeware, Spectacles Inc, Harkla, Eyehear +16 more (view full list) |
Looking for a particular Luminopia employee's phone or email?
Scott Xiao is the Co-Founder and CEO of Luminopia.
16 people are employed at Luminopia.
Luminopia is based in Cambridge, Massachusetts.